179 related articles for article (PubMed ID: 10494510)
21. Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck. Report on Intergroup Study 0034.
Hong WK
Int J Radiat Oncol Biol Phys; 1992; 23(4):885-6. PubMed ID: 1618679
[No Abstract] [Full Text] [Related]
22. [Adjuvant chemotherapy with S-1 for advanced head and neck carcinoma].
Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Katori H; Horiuchi C; Taguchi T; Yoshida T; Toth G
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():172-8. PubMed ID: 16897997
[TBL] [Abstract][Full Text] [Related]
23. Concurrent chemoradiation in the treatment of head and neck cancer.
Haffty BG
Hematol Oncol Clin North Am; 1999 Aug; 13(4):719-42, vi-vii. PubMed ID: 10494509
[TBL] [Abstract][Full Text] [Related]
24. Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure.
Argiris A; Haraf DJ; Kies MS; Vokes EE
Oncologist; 2003; 8(4):350-60. PubMed ID: 12897332
[TBL] [Abstract][Full Text] [Related]
25. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma.
Rosenthal DI; Ang KK
Semin Radiat Oncol; 2004 Apr; 14(2):153-66. PubMed ID: 15095261
[TBL] [Abstract][Full Text] [Related]
26. Sequential chemotherapy and radiotherapy in advanced head and neck cancer.
Stell PM; Dalby JE; Strickland P; Fraser JG; Bradley PJ; Flood LM
Clin Radiol; 1983 Jul; 34(4):463-7. PubMed ID: 6409493
[TBL] [Abstract][Full Text] [Related]
27. Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer.
Fu KK; Cooper JS; Marcial VA; Laramore GE; Pajak TF; Jacobs J; Al-Sarraf M; Forastiere AA; Cox JD
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):425-38. PubMed ID: 8655364
[TBL] [Abstract][Full Text] [Related]
28. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.
Kovács AF; Mose S; Böttcher HD; Bitter K
Strahlenther Onkol; 2005 Jan; 181(1):26-34. PubMed ID: 15660190
[TBL] [Abstract][Full Text] [Related]
29. Evolving role of surgery after induction chemotherapy and primary site radiation in head and neck cancer.
Norris CM; Busse PM; Clark JR
Semin Surg Oncol; 1993; 9(1):3-13. PubMed ID: 8356382
[TBL] [Abstract][Full Text] [Related]
30. Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database.
Laramore GE; Scott CB; Schuller DE; Haselow RE; Ervin TJ; Wheeler R; al-Sarraf M; Gahbauer RA; Jacobs JR; Schwade JG
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1011-6. PubMed ID: 8262821
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant chemotherapy.
Bingham HG
Surg Clin North Am; 1986 Feb; 66(1):183-8. PubMed ID: 2418517
[TBL] [Abstract][Full Text] [Related]
32. Induction chemotherapy for squamous cell head and neck cancer: a neverending story?
Benasso M
Oral Oncol; 2013 Aug; 49(8):747-52. PubMed ID: 23683948
[TBL] [Abstract][Full Text] [Related]
33. High-grade acute organ toxicity as positive prognostic factor in adjuvant radiation and chemotherapy for locally advanced head and neck cancer.
Wolff HA; Daldrup B; Jung K; Overbeck T; Hennies S; Matthias C; Hess CF; Roedel RM; Christiansen H
Radiology; 2011 Mar; 258(3):864-71. PubMed ID: 21339350
[TBL] [Abstract][Full Text] [Related]
34. Changing role of chemotherapy in treatment of head and neck cancer.
Mead GM; Jacobs C
Am J Med; 1982 Oct; 73(4):582-95. PubMed ID: 6181680
[TBL] [Abstract][Full Text] [Related]
35. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation.
Vergeer MR; Doornaert P; Leemans CR; Buter J; Slotman BJ; Langendijk JA
Radiother Oncol; 2006 Apr; 79(1):39-44. PubMed ID: 16632006
[TBL] [Abstract][Full Text] [Related]
36. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials.
Haffty BG; Son YH; Sasaki CT; Papac R; Fischer D; Rockwell S; Sartorelli A; Fischer JJ
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):241-50. PubMed ID: 7691784
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy for head and neck cancer: progress and controversy in the management of patients with M0 disease.
Clark JR; Frei E
Semin Oncol; 1989 Aug; 16(4 Suppl 6):44-57. PubMed ID: 2669137
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy and combined modality therapy in head and neck cancer.
Hamasaki VK; Vokes EE
Curr Opin Oncol; 1993 May; 5(3):508-17. PubMed ID: 8494912
[TBL] [Abstract][Full Text] [Related]
39. [Recommendation of the Hungarian Society for Face, Mandible and Oral Surgery in the indication of supportive therapy with Avemar].
Barabás J; Németh Z
Orv Hetil; 2006 Sep; 147(35):1709-11. PubMed ID: 17051748
[No Abstract] [Full Text] [Related]
40. Pharmacotherapy of head and neck cancer.
Nwizu T; Adelstein D
Expert Opin Pharmacother; 2015; 16(16):2409-22. PubMed ID: 26513647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
